Genespire is sponsoring a study, InforMMA, to better understand methylmalonic acidaemia (MMA), a rare inherited metabolic disorder. The multi-centre observational study, InforMMA, is being conducted at specialized clinical sites in Italy, Spain, United Kingdom, and United States to help improve scientific understanding of how MMA progresses over time.

Observational research plays an important role in building knowledge about rare diseases and supporting the development of future treatment.

More information about MMA research can be found at https://clinicaltrials.gov/study/NCT07432880

Learn more about Genespire: www.genespire.com

Fun Fact: “inforMMA” is a play on the Italian ‘he/she Informs.’ The name was chosen as it reflects how the participants are informing about their disease and reflects Genespire roots as an Italian organization originating at San Raffaele Telethon Institute for Gene Therapy (SR-Tiget).